| EDSA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the EDSA market cap history going back to 6/10/2019:
Also see: EDSA Shares Outstanding History and EDSA YTD Return |
EDSA Market Cap History — Edesa Biotech Capitalization Over Time
As of 5/13/2026 Edesa Biotech has a market cap of 135.51 million. Investors often follow the EDSA market cap history to compare the size of the company over time.
This page shows EDSA market capitalization trends over time, with 30 market cap datapoints presented, dating back to 6/10/2019.
| EDSA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EDSA Historical Market Cap: +62.62% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDSA Stock Price Chart |
| About Edesa Biotech Inc |
| Edesa Biotech, Inc. is a Canada-based clinical-stage biopharmaceutical company developing various ways to treat inflammatory and immune-related diseases. Co.'s advanced drug candidate is EB05 (paridiprubart), a monoclonal antibody developed for acute and chronic disease indications that involve dysregulated innate immune responses. It is evaluating EB05 in a Phase III study as a potential treatment for acute respiratory distress syndrome (ARDS), a life-threatening form of respiratory failure. In addition, the Co. is developing an sPLA2 inhibitor, EB01 (daniluromer), as a topical treatment for chronic allergic contact dermatitis (ACD), a common occupational skin condition. We show 30 historical shares outstanding datapoints in our EDSA shares outstanding history coverage, used to compute EDSA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing EDSA market cap history over the course of time is important for investors interested in comparing EDSA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of EDSA versus a peer is one thing; comparing EDSA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like EDSA can fluctuate over the course of history. With this page we aim to empower investors researching EDSA by allowing them to research the EDSA market cap history. |
| EDSA Current Stock Quote |
Quotes delayed 20 minutes  Free EDSA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| EDSA Share Performance |
| Market Cap Peers |
| Edesa Biotech (EDSA) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
EDTK Market Cap History EDTX Market Cap History EDUT Market Cap History EEIQ Market Cap History EEMA Market Cap History EEMS Market Cap History EEMV Market Cap History EFAD Market Cap History EFAS Market Cap History EFHT Market Cap History More Miscellaneous companies » |
EDSA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
